# Charles River Laboratories International, Inc. (CRL)

> Charles River Laboratories International, Inc. (CRL) trades at $314.32 (-4.15%) as of 7:42:28 PM EST on Nov 20, 2026, -7.46% over the past month. Market cap is $15.06B, with 2.2 days to cover in short interest.

Canonical: https://massive.com/quote/crl
Data as of: 2026-11-21T00:42:28.132Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$314.32** -13.60 (-4.15%)
At close · 15-minute delayed
NYSE · usd

After hours: **$315.43** +1.11 (+0.35%)
As of 7:42:28 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Charles River Laboratories International, Inc. (CRL) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -4.15% |
| 1W | -7.00% |
| 1M | -7.46% |
| YTD | +57.57% |
| 1Y | +84.42% |
| 52-wk range | $146.20 – $379.63 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for CRL: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $310.52 – $327.23 |
| Open | $324.98 |
| Prev close | $327.93 |
| Volume | 1.15M |
| Market cap | $15.06B |
| Shares out | 47.92M |

## Valuation and profitability ratios

Valuation and profitability ratios for Charles River Laboratories International, Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 391.01 |
| P/S | 3.95 |
| P/B | 4.87 |
| P/FCF | 58.32 |
| ROE | 1.3% |
| ROA | 0.5% |
| Debt/Equity | 0.76 |
| Div yield | 0.00% |

As of Nov 19, 2026

## Insider trading

[Charles River Laboratories International, Inc. (CRL) insider trading](https://massive.com/quote/crl/insider-trading.md): open-market Form 4 buys and sells by Charles River Laboratories International, Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events Charles River Laboratories International, Inc. has disclosed to the SEC on Form 8-K.

- Nov 9, 2026 · Acquisition agreement
  “On November 9, 2026, Charles River Laboratories International, Inc. ("Charles River") issued a press release announcing that it has entered into definitive agreements to acquire Frontage Holdings Corporation's bioanalysis and DMPK operations in Exton, Pennsylvania.”
- Nov 4, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 4, 2026, Charles River Laboratories International, Inc. issued a press release providing financial results for the third quarter ended September 26, 2026.”
- Sep 24, 2026 · Investor presentation
  “On September 24, 2026, in connection with its Investor Day, Charles River Laboratories International, Inc. (the "Company") issued a press release... The Company will host its Investor Day beginning at 9:00 a.m. Eastern time today, which will be live webcast and archived on the Company's Investor Relations website. To access the webcast and corresponding slide presentation, visit http://ir.criver.com.”
- May 11, 2026 · Annual meeting results
  “At the Company's Annual Meeting, the following proposals were adopted by the votes specified below. (a) The following twelve (12) directors were elected to serve until our 2027 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below.”
- Feb 25, 2026 · [Guidance issuance or update](https://massive.com/quote/sec-filings/8-k/guidance-updates.md)
  “The Company is updating its financial guidance for 2026, which was initially provided on February 18, 2026, for the impact of the planned divestitures. The updated financial guidance assumes both transactions close during the second quarter of 2026. The planned divestitures are expected to reduce reported revenue by slightly more than $200 million in 2026, including more than a 50-basis-point reduction to organic revenue growth guidance.”

## Similar companies

Public companies in a similar business to Charles River Laboratories International, Inc..

- [IQV](https://massive.com/quote/iqv.md) IQVIA Holdings Inc. (-1.89%)
- [RVTY](https://massive.com/quote/rvty.md) Revvity, Inc. (-4.20%)
- [TMO](https://massive.com/quote/tmo.md) Thermo Fisher Scientific, Inc. (-2.79%)
- [TECH](https://massive.com/quote/tech.md) Bio-Techne Corp. (-0.04%)
- [A](https://massive.com/quote/a.md) Agilent Technologies Inc. (-2.83%)
- [ICLR](https://massive.com/quote/iclr.md) Icon Plc (-1.92%)

Daily change in the latest session, 15-minute delayed.

## CRL short interest

How heavily CRL is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 2.2 |
| Short interest | 2.99M |
| Avg volume | 1.34M |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## CRL news

The latest news and headlines about Charles River Laboratories International, Inc. (CRL).

- [Charles River Stock Surges 102.3% in a Year: What's Fueling the Drive?](https://www.zacks.com/stock/news/3033431/charles-river-stock-surges-102-3-in-a-year-what-s-fueling-the-drive?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-3033431) · Zacks Investment Research · Nov 20, 2026 · positive sentiment
- [Should You Continue to Hold Charles River Stock in Your Portfolio?](https://www.zacks.com/stock/news/3031785/should-you-continue-to-hold-charles-river-stock-in-your-portfolio?cid=CS-ZC-FT-analyst_blog|rank_focused-3031785) · Zacks Investment Research · Nov 18, 2026 · neutral sentiment
- [GMRS vs. CRL: Which Stock Should Value Investors Buy Now?](https://www.zacks.com/stock/news/3028862/gmrs-vs-crl-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-fundamental_analysis|yseop_template_3-3028862) · Zacks Investment Research · Nov 12, 2026 · positive sentiment
- [Here's Why Charles River Laboratories (CRL) is a Strong Momentum Stock](https://www.zacks.com/stock/news/3026424/here-s-why-charles-river-laboratories-crl-is-a-strong-momentum-stock?cid=CS-ZC-FT-fundamental_analysis|zacks_education_momentum_score-3026424) · Zacks Investment Research · Nov 9, 2026 · positive sentiment
- [Charles River Q3 Earnings & Revenues Top Estimates, Stock Rises](https://www.zacks.com/stock/news/3023067/charles-river-q3-earnings-revenues-top-estimates-stock-rises?cid=CS-ZC-FT-analyst_blog|earnings_article-3023067) · Zacks Investment Research · Nov 4, 2026 · positive sentiment

## About Charles River Laboratories International, Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

| Measure | Value |
| --- | --- |
| Exchange | NYSE |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
| Employees | 19.7K |
| Listed | Jun 23, 2000 |

[Company website](https://www.criver.com)

## FAQ

### What is the Charles River Laboratories International, Inc. (CRL) stock price today?

Charles River Laboratories International, Inc. (CRL) is trading at $314.32 (-4.15% on the day) as of 7:42:28 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Charles River Laboratories International, Inc.?

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models…

### What is the short interest in CRL?

As of Oct 30, 2026, CRL has 2.99M shares short and 2.2 days to cover.

### What exchange is CRL listed on?

Charles River Laboratories International, Inc. (CRL) trades on NYSE in USD, in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry.

## Live data

Prices here are 15-minute delayed. For real-time CRL quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=CRL`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Charles River Laboratories International, Inc. (CRL) insider trading](https://massive.com/quote/crl/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
